To maintain U.S. leadership, the policy and regulatory environment needs to keep pace with innovations happenings in labs across the country. The ontly thing that can impede long-term U.S. biotechnology leadership is short sighted policy proposals that stifle innovation and scare away investment. Entrepreneurs and investors need policy certainty to be successful at the incredibly difficult task of drug development, where 90% of endeavors fail.
Creating new drugs through biotechnology is at the risky end of a business in which superhuman stamina and bottomless pockets are minimum requirements
